Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Impact of CYP2D6 Genotype on the Clinical Effects of Tamoxifen Using With Samples From Prospective Randomized Multicenter Study

NCT00973037 is registered in ClinicalTrials.gov with Korea University Anam Hospital as lead sponsor.

NCT NCT00973037
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00973037 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Impact of CYP2D6 Genotype on the Clinical Effects of Tamoxifen Using With Samples From Prospective Randomized Multicenter Study
Lead sponsor
Korea University Anam Hospital
Phase
Observational
Overall status
Unknown status
Start date
March 31, 2009
Completion date
April 30, 2016
Enrollment
922 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

breast neoplasms, cyp2d6, genotype, tamoxifen